Toggle light / dark theme

Big Blue is cool again according to investors.


NEW YORK: Here’s a vexing question for artificial mega-brain Watson: Why is IBM stock surging? Big Blue’s market value rose about $6 billion after the computer giant agreed on Thursday to buy Truven Health Analytics for $2.6 billion. Giving IBM’s artificial-intelligence platform more data to chew on is useful, but investors’ glee over an opaque addition to an enigmatic business effort is confusing.

Big Blue’s top line has been shrinking steadily for nearly four years. In the fourth quarter of 2015, all major divisions had declining sales, with overall revenue falling 8.5 percent compared with the same period a year earlier. Clients need less of IBM’s hardware, and its software and consulting businesses are faltering in competition with rivals’ cloud-based versions.

The upshot is a falling share price. It has dropped about 25 percent in the past four years, while the S&P 500 has risen about 40 percent.

Read more

Like the idea of using Google to vote online for the best airline, steamed dumpling or health app?

What about using Google to vote for governor or president? That seems to be Google’s plan.

The search giant received a U.S. patent for a voting user interface (VUI). The interface would appear along with search results and would allow the user to vote for one or more contestants competing in a campaign.

Read more

Interesting read mostly about the SV income divide. Bottom line, is that we need technology in many ways to save humanity. I know many are questioning that remark. However, since technology has been existence, many have gained through medical treatments, research, and accessibilities to connect with people like we never did in the past. The future of tech holds great promise as a tool to help researchers and medical teams to eliminate cancer, neurological diseases and disorders, enabling the blind to see and the paralyzed to walk. The good does outweigh the bad.


Editor’s note: Income equality — a hot-button political issue — is not going to improve; technology is about to make things much worse. It will, over the next decade, begin to disrupt almost every industry, wipe out millions of jobs, and make the rich even richer. Even though everyone will be able to live better and healthier lives and benefit from the technology advances, the widening gap will cause greater resentment and create a larger cauldron of dissent. This is something we need to be prepared for, writes former Triangle tech entrepreneur-turned-academic Vivek Wadhwa.

SAN FRANCISCO - There are very few issues that Donald Trump, Bernie Sanders, Ted Cruz, and Hillary Clinton all agree on. One of them is the growing problem of inequality in income and wealth. From the extreme left to the extreme right, everyone is angry about the one percent who have the majority of the wealth. There has always been an income and wealth gap, but the divide between average worker and the very wealthy has not been so great since the Roaring Twenties. This is fueling the rise of both the Tea Party and the socialists.

Income equality is not going to improve; technology is about to make things much worse. It will, over the next decade, begin to disrupt almost every industry, wipe out millions of jobs, and make the rich even richer. Even though everyone will be able to live better and healthier lives and benefit from the technology advances, the widening gap will cause greater resentment and create a larger cauldron of dissent. This is something we need to be prepared for.

Read more

I was waiting for this HIPAA’s new guidelines for mobile apps (focuses a lot on IAM); this is only the first wave. We will see more when more AI is launched.


Federal regulators have issued new guidance, including material to clarify for healthcare entities and software developers various scenarios where HIPAA regulations might apply to mobile health applications, including situations when patients use smartphones to collect or transmit personal health data.

See Also: 2015 Breach Preparedness and Response Study: The Results

Some privacy and security experts say the new mobile application guidance material from the Department of Health and Human Services’ Office for Civil Rights addresses a topic that is not only a current source of confusion for many covered entities and business associates, but also is likely to become increasingly complex as more consumers use smartphones and other devices to help manage chronic illnesses and other health issues.

Read more

Good news and hope for Parkinson disease patients.


Erika Jucumin, a physician assistant at Neurology Associates in Ormond Beach, programs and monitors a deep brain stimulator for patients with Parkinson’s disease, dystonia and other neurological disorders.

As a result, Jacumin said she has seen many amazing turn-arounds in patients’ health. She spoke to The News-Journal about the device.

NAME: Erika Jacumin.

Read more

https://youtube.com/watch?v=l62jlwgL3v8

A group of scientists are calling on the WHO to classify aging as a disease, asserting that we need to create a better classification for what happens to our bodies as we get older.

A new controversy is brewing, as one group of scientists is recommending that aging be considered a disease.

Scientists from Insilico Medicine are highlighting the need to create a more granular and applied classification for what happens to our bodies when we age. Their work is outlined in a recent paper published in Frontiers in Genetics. The classification that they argue for is based on the World Health Organization’s (WHO) International Statistical Classification of Diseases and Related Health Problems (ICD-11), which is expected to be finalized in 2018.

Read more

Unity Biotechnology today announced that it is developing medicines to treat and eliminate age-related diseases and increase healthspan, or the amount of time an individual lives in good health.

BrewLife on behalf of Unity Biotechnology.

Read more

This week, Kathy Niakan, a biologist working at the Francis Crick Institute in London received the green light from the UK’s Human Fertilisation and Embryology Authority to use genome editing technique CRISPR/Cas9 on human embryos.

Niakan hopes to answer important questions about how healthy human embryos develop from a single cell to around 250 cells, in the first seven days after fertilization.

By removing certain genes during this early development phase using CRISPR/Cas9, Niakan and her team hope to understand what causes miscarriages and infertility, and in the future, possibly improve the effectiveness of in-vitro fertilization and provide better treatments for infertility.

Read more